The increasing problem of treatment-resistant fungal infections: a call for antifungal stewardship programs

Aditya K Gupta1,2, Maanasa Venkataraman2, Helen J Renaud2

  • 1Division of Dermatology, Department of Medicine, University of Toronto, Toronto, ON, Canada.

Insights

Antimicrobial stewardship programs are common, but few address fungal infections. Antifungal stewardship is needed to combat rising antifungal resistance and treatment failures.

Area of Science:

  • Public Health
  • Infectious Diseases
  • Pharmacology

Background:

  • Antimicrobial stewardship (AMS) programs are established globally, primarily targeting bacterial infections and antibiotic resistance.
  • However, a significant gap exists in the inclusion of antifungal stewardship (AFS) within these programs.
  • Rising rates of fungal infections and diagnostic challenges contribute to antifungal overuse.

Purpose of the Study:

  • To highlight the critical need for integrating antifungal stewardship (AFS) into existing antimicrobial stewardship (AMS) frameworks.
  • To underscore the growing problem of antifungal resistance driven by increased exposure to antifungal agents.
  • To advocate for global recognition and implementation of AFS programs.

Main Methods:

  • Literature review on current AMS practices and antifungal resistance trends.
  • Analysis of the incidence and impact of fungal infections.
  • Synthesis of evidence supporting the necessity of AFS.

Main Results:

  • Antifungal stewardship is underrepresented in global AMS initiatives.
  • Increased antifungal use correlates with the emergence of antifungal resistance.
  • Reports of treatment failures due to resistant fungal infections are mounting.

Conclusions:

  • Antifungal stewardship (AFS) is an essential, emerging component of antimicrobial stewardship (AMS).
  • There is a growing body of evidence necessitating the development and global adoption of AFS programs.
  • AFS requires urgent attention to address the increasing threat of antifungal resistance.

Related Concept Videos

Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
774
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
242
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
726
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.5K
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
3.4K
Antibiotic Selection00:57

Antibiotic Selection

Overview
57.1K